PubHawk
Chin Med J (Engl) October 2023 PMID 37442759

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases.

Xiaofeng Chen, Hua Zhang, Sichong Ren, Yangnan Ding, Naznin Sultana Remex, Md Shenuarin Bhuiyan, Jiahua Qu, Xiaoqiang Tang

Full text PDF Download social card

Mentions

3
Peak: 2 in Aug 2023
across 2 sources since Aug 2023

Extended reach

535
potential audience

Total likes

2

Video views

17

Mentions per month

Aug 2023 – Jan 2024

Where it's discussed

  • X / Twitter2 posts
  • YouTube1 videos

AI synopsis

What people are saying

The discussions display enthusiasm about the potential of microbiota-targeted therapies, with phrases like 'promising approach' and 'significant role' indicating both interest and perceived impact. The tone is analytical yet optimistic, especially when referencing how modifying gut bacteria could reduce cardiovascular risks, reflecting a balanced engagement with the scientific content.

AgreementModerate agreement

Most discussions express alignment with the article's emphasis on the importance of gut microbiota in cardiovascular health, indicating a consensus that the research's conclusions are valuable.

InterestHigh interest

Participants show high curiosity, frequently referencing the relevance of microbiota-modifying therapies and how this research impacts future treatment approaches.

EngagementModerate engagement

Posts delve into specifics, exploring mechanisms like TMAO's role and potential interventions, demonstrating moderate deep analysis.

ImpactModerate impact

The discussions highlight the article's potential to influence future research directions and clinical practices, suggesting a moderate but meaningful impact.

Abstract in brief

  • The gut microbiota plays a significant role in the development and progression of cardiovascular diseases such as heart failure, atherosclerosis, and hypertension, acting like an endocrine organ that secretes important metabolites.
  • Dysfunctions in gut microbiota can impact cardiovascular health by influencing the levels of key metabolites like trimethylamine N-oxide (TMAO), short-chain fatty acids, and phenylacetylglutamine, which can either promote or inhibit disease processes.
  • The review emphasizes the potential of therapies aimed at modifying the gut microbiota and its metabolites as a promising approach to prevent or treat cardiovascular diseases.
Read the full abstract

Top posts

Most liked on X and Bluesky
CMJ
@ChinMedJ · X

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases https://t.co/sjOEMyRxoi

Aug 17, 2023 · 1 like · 1 share · 440 followers View post →
XX
@tang_xiaoqiang · X

RT @ChinMedJ: Gut microbiota and microbiota-derived metabolites in cardiovascular diseases https://t.co/sjOEMyRxoi

Aug 20, 2023 · 1 share · 75 followers View post →

All mentions

XX
@tang_xiaoqiang · X

RT @ChinMedJ: Gut microbiota and microbiota-derived metabolites in cardiovascular diseases https://t.co/sjOEMyRxoi

Aug 20, 2023 · 1 share · 75 followers View post →
CMJ
@ChinMedJ · X

Gut microbiota and microbiota-derived metabolites in cardiovascular diseases https://t.co/sjOEMyRxoi

Aug 17, 2023 · 1 like · 1 share · 440 followers View post →